✦ LIBER ✦

Structural organization and analysis of the human fumarylacetoacetate hydrolase gene in tyrosinemia type I

✍ Scribed by Awata, Hisataka; Endo, Fumio; Tanoue, Akito; Kitano, Akito; Nakano, Yoshikuni; Matsuda, Ichiro

Book ID: 123195884
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 406 KB
Volume: 1226
Category: Article
ISSN: 0925-4439
DOI: 10.1016/0925-4439(94)90025-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations in the fumarylacetoacetate hyd

Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: Overview

✍ Maryse St-Louis; Robert M. Tanguay 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 2 views

Tyrosinemia type I is an inborn error of metabolism caused by a deficiency in the last enzyme of the tyrosine catabolic pathway, fumarylacetoacetate hydrolase (FAH). The disease has been reported worldwide with varying incidence. Recently, there has been considerable progress in identifying mutation

Mutations of the fumarylacetoacetate hyd

Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I

✍ Markus Grompe; Muhsen Al-Dhalimy 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 777 KB

Tyrosinemia type I is an autosomal recessive inborn error of metabolism caused by deficiency of the enzyme fumaryl acetoacetate hydrolase (FAH, EC 3.7.1.2.). We have used reverse transcription and the polymerize chain reaction to amplify the peptide coding region of the FAH cDNA from four patients w

Six novel mutations in the fumarylacetoa

Six novel mutations in the fumarylacetoacetate hydrolase gene of patients with hereditary tyrosinemia type I

✍ Cynthia Timmers; Markus Grompe 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB 👁 2 views

Correction of Fumarylacetoacetate Hydrol

Correction of Fumarylacetoacetate Hydrolase Deficiency (Type I Tyrosinemia) in Cultured Human Fibroblasts by Retroviral-Mediated Gene Transfer

✍ D. Phaneuf; M. Hadchouel; R.M. Tanguay; C. Brechot; N. Ferry 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 405 KB

Spectrum of mutations in the fumarylacet

Spectrum of mutations in the fumarylacetoacetate hydrolase gene of tyrosinemia type 1 patients in northwestern Europe and Mediterranean countries

✍ AJIW Bergman; IET van den Berg; W Brink; BT Poll-The; JK Ploos van Amstel; R Ber 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB 👁 2 views

Hereditary tyrosinemia type 1 (HT1) is a rare metabolic disease caused by a deficient activity of the enzyme fumarylacetoacetase (FAH). To investigate the molecular heterogeneity of tyrosinemia, the geographic distribution and the genotype-phenotype relationship, we have analyzed the FAH genotype of

Mutation analysis of the FAH gene in Isr

Mutation analysis of the FAH gene in Israeli patients with tyrosinemia type I

✍ Orly N. Elpeleg; Avraham Shaag; Elizabeth Holme; Ghaleb Zughayar; Suzi Ronen; Dr 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 1 views

Thirteen Israeli patients with type I tyrosinemia were studied. To the best of our knowledge, this group represents all of the patients that were diagnosed in Israel during the years 1987-1997. Their age of onset was variable but all the patients suffered from liver disease at presentation. Six died